amines in like manner; that is to say, by deamination only in the presence of oxygen.
If hypertension were due to a pressor amine released by kidneys which are deficient in oxygen supply it would seem rewarding to ascertain the effect upon the blood pressure of hypertensive animals of certain substances capable of altering pressor amines. Because the most powerful pressor substances known contain phenolic configurations in their molecules, it is reasonable to study first enzymes active against that portion of their structure, especially since the known amine oxidases have not been purified. For this reason pure specific oxidative enzymes were selected for this investigation.
Tyrosinase, very common in fruits and vegetables, has the property of oxidizing mono-and ortho-di-hydroxyphenols to quinones (6) . When certain physiologically active phenolic amines are acted upon by this enzyme, derivatives are formed which are inactive on the vascular system. The conversion of adrenalin to adrenochrome and tyramine to melanin are examples (7) . An attempt was made, therefore, to learn the effect of tyrosinase upon the blood pressure of hypertensive animals.
Materials and Methods
The preparation of the enzyme used in this study was obtained from Dr. J. M. Nelson who has isolated it from mushrooms (8) . Tyrosinase is a water-soluble protein combining in itself two types of enzymatic activity. It catalyzes the oxidation of monohydroxyphenols to catechol derivatives and also the oxidation of catechol derivatives to orthoquinones; thus completely destroying the phenolic configuration of these compounds (Text- fig. 1 ). This makes an ideal preparation for the present use, since its action applies to all compounds containing a free mono-or ortho-di-hydroxyphenolic configuration.
Forty-four rats were made hypertensive by one of three methods. One was that of Goldblatt as reported by Rytand (9) . One renal artery was partially constricted, in a few instances the other kidney being removed. In rats at least, this procedure induced hypertension quite uniformly, whether or not the normal kidney was left in place (Table I) .
The second method involved the production of unilateral hydronephrosis; since it has not been reported it will be described in detail. Rats were anesthetized by pentobarbital sodium injected into the peritoneum. A diagonal incision was made along the course of the lowest rib on the left, extending anteriorly and caudally to the lower third of the abdomen. The ureter was exposed as it left the kidney, and dissected free to a point near its insertion in the bladder. It was there tied, cut, and brought out through the skin in the upper angle of the wound. The end was sutured to the skin and the wound closed. At the end of a day or two it was found that the part of the ureter outside of the animal had sloughed, and as healing took place with resultant contraction of scar tissue, hydronephrosis developed while the kidney continued to function. In no case was hydronephrosis of marked degree, and hypertension, as judged by elevation of blood pressure and cardiac hypertrophy, consistently resulted (Table II) .
The third method involved traumatic injury to one kidney. Rats were anesthetized and the left kidney isolated in a fold of skin in the flank. By placing the handle of a clamp over the kidney it could be firmly fixed in position. The kidney was then pounded gently with a blunt object through the unopened skin. Hypertension resulted in about half of these animals (Table III) .
Rats were regarded as exhibiting arterial hypertension when both of the following phenomena were observed. (7) . Both tyramine and hydroxytyramine are pressor substances, the latter being the stronger. of 110 mm. Hg. (b) Enlargement of the heart, its weight being 12 per cent or more than that expected, according to the formulae:
Males: Heart weight (mg.) 12.6 body weight (gm.)0-7. + 8 One animal with a diastolic pressure of 102 mm. Hg was included in this series because its cardiac enlargement was 27 per cent more than expected. The hearts of none of the normal rats were hypertrophic, although the diastolic pressures of six were greater than 110 mm. Hg (Tables IV and VI) . When injections were to be made, rats were anesthetized with pentobarbital sodium given into the peritoneal cavity. The right femoral artery was exposed, and a drop of strong novocaine solution was placed on it to prevent contraction. A 23 gauge needle connected to Hamilton's optical manometer was inserted into the artery through a small incision and tied. The femoral vein was then isolated and cannulated. A small amount All rats were males. * Animals injected with tyrosinase.
t Animal in shock when blood pressure was measured. 
of heparin was injected intravenously to prevent clotting in the needle of the manometer. It was sometimes found necessary to perform tracheotomy. One subsequent measurement of blood pressure and rarely two could be made by using the left femoral artery.
The Effect of Tyrosinase on Hypertensive Rats
The injection of tyrosinase into 16 hypertensive rats was always followed by a fall of blood pressure to normal (Table V) . In no case did the blood pressure subsequently rise to previous levels. The intravenous injection of this enzyme into 22 normal rats gave variable results (Table VI) . The action of this material was always delayed, no effect being observed, except for a slight initial depression, until 5 to 15 minutes had elapsed ( route lay between 180 and 500 units.' The only toxic effect observed subsequently was the development of diarrhea in three of the animals, a day or two later. In every hypertensive rat the heart rate was slowed when the injection had taken effect; this reduction was abolished by the administration of atropine without altering the lowered blood pressure. Injections of the enzyme when it had been inactivated by heat (90 0 C. for 10 minutes) did not affect blood pressure.
Later effects upon blood pressure were observed in five animals, in none of which did hypertension reappear (Table V) . These rats did not lose weight and seemed to be healthy in every respect.
The Effect of Tyrosinase on Hypertensive Dogs
Chronic arterial hypertension was induced in dogs by the method of Goldblatt. Usually one renal artery was partially constricted and the other kidney removed, although one dog exhibited persistent hypertension for many months after partial constriction of one renal artery alone. Estimations of blood pressure were made by the use of Hamilton's optical manometer, the needle of which was inserted into the femoral artery. Injections of tyrosinase were made by the intravenous or, in two instances, by the intramuscular route.
Effects somewhat similar to those in rats were seen. Single injections into four hypertensive unanesthetized dogs were followed by marked falls in blood pressure lasting from 3 to 48 hours. Doses varied from 5000 to 20,000 units (10 to 40 mg. protein by dry weight). In three normal dogs there was less change in pressure (Table VII A) .
Because the effects of the administration of this enzyme were of relatively short duration, four dogs were treated by daily intravenous injections of 200 units per kilo (Table VII B) . The blood pressures of all fell slowly after several days, remaining considerably reduced for several days after the injections were discontinued, and slowly returning to the previous level. Similar treatments given to two normal dogs resulted in one in a rise in the level of blood pressure and in the other in a slight fall (Text-figs. 4 and 5).
Dogs remained healthy and did not lose weight. When large doses were given by the intravenous route, certain symptoms and signs were noted for an hour or two after the injections. These consisted of marked fall in blood pressure, vomiting, diarrhea, and bradycardia. Occasionally there was a rise in body temperature of 1-2°C. 24 hours later bradycardia sometimes persisted although the animals appeared otherwise unchanged. In two experiments bradycardia was abolished after the administration of atropine, although there was no rise in the level of the blood pressure. I One unit has been defined as the amount of enzyme required to cause a solution of hydroquinone and catechol to absorb oxygen at the rate of 10 c.mm. per minute (10) . Renal function was measured roughly by the amount of urea nitrogen in the blood. In every instance values were less after the injection of tyrosinase ( Fig.4 . A, dog 5-2,hypertensive. B, dogs5-6and6-1, normal.
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The Duration of the Presence of Tyrosinase in the Blood Stream
After single intravenous injections, tyrosinase was detected in the blood of dogs for 24 hours (Text-fig. 6 ). No trace of this enzyme has been found Rune(
in the blood of dogs or of human beings after subcutaneous or intramuscular injections. As yet, no correlation between the amount of tyrosinase present in the blood and the duration of the fall in blood pressure has been established. Although the enzyme is active in dogs when given by the intramuscular route its presence cannot be demonstrated in the blood.
The Mode of Action of Tyrosinase in Hypertension
Attempts were made to ascertain the mode of action of this enzyme in animals, especially as regards its effect upon various pressor substances. 25 rats and eight dogs, both hypertensive and normal, were used in brief experiments.
Renal blood flow was measured in dogs by the method of Schroeder and Steele (11), using a thermostromuhr. Blood pressures were recorded by Hamilton's manometer.
Six solutions were used: Renin was prepared by Dr. Alfred E. Mirsky and concentrated to a point at which 0.1 cc. consistently produced a pressor response in rats weighing 300 gin. or more. The dose of this material in normal dogs amounted to 1.0 cc. The solution of tyrosinase contained 500 units per cc. The solution of catechol-hydroquinone (hereafter called C-H) contained 5.0 mg. hydroquinone and 0.1 mg. catechol per cc., buffered in a phosphate solution at pH 6.5, a standard substrate for the enzyme. Adrenalin consisted of the usual 1:1000 solution diluted with normal saline according to the amount required. The solution of tyramine hydrochloride contained 4.0 mg. per cc. Angiotonin was obtained from Dr. Irvine H. Page; 0.05 cc. was one "rat dose" raising the diastolic pressure 50 mm. Hg after intravenous injection.
Tyrosinase and Renin.-When a single dose of renin which had not been freshly dialyzed was shaken with a single dose of tyrosinase for 20 minutes, it was found that the renin was completely inactivated. When freshly dialyzed renin was used, the response of the blood pressure of dogs and rats was lessened but not abolished. The addition to this mixture of the solution of catechol-hydroquinone resulted in complete inactivation of the renin, C-H itself having no effect when mixed with renin alone (Table VIII) . The addition of whole blood to a renin-C-H or to a renin-tyrosinase mixture resulted in marked fall in blood pressure.
Experiments were performed in the Warburg apparatus to ascertain whether tyrosinase acted directly upon renin, or acted through the medium of some other substance. Renin which had stood for several weeks in the cold was shaken with tyrosinase; absorption of oxygen occurred, suggesting that a substrate for tyrosinase was present. No oxygen was absorbed when renin which had been freshly dialyzed was treated in the same manner. A mixture of fresh renin, tyrosinase, and C-H absorbed oxygen (owing to the presence of C-H, a substrate) and was inactive on the blood pressure. In the first instance, therefore, some product of the deterioration of renin acted as a substrate for the enzyme and allowed inactivation of renin. Inactivation likewise occurred when C-H had reacted with tyrosinase.
Tyrosinase and Angiotonin.-When tyrosinase and angiotonin, amounting to one rat dose of each, were shaken at room temperature for 20 minutes and injected intravenously in rats, the mixture was found to have about one-third of the pressor activity of angiotonin alone. The addition of catechol did not change the result. But when 0.1 cc. of rat plasma or rabbit serum was added to tyrosinase and angiotonin, the resultant mixture, after shaking, was found to be completely inactive on the blood pressure (Fig. 2 A) . Substitution of gelatin for serum resulted in partial inactivation. These results were observed in five experiments. As was the case with adrenalin, the injection of tyrosinase before or immediately after the administration of angiotonin resulted in a modified pressor response.
When tyrosinase (two and one-half units) and angiotonin (one rat dose) were shaken together in the Warburg apparatus, oxygen was absorbed slowly, and the resulting mixture was found to have lost none of its pressor activity. The addition of a small amount of serum resulted in more rapid and complete absorption of oxygen, and this mixture was completely inactive on the blood pressure of rats (Fig. 2 B) . Tyrosinase and serum, or tyrosinase and gelatin, did not cause absorption of oxygen, and were inactive on the blood pressure. Several hours of shaking in the Warburg apparatus were necessary to cause complete inactivation of angiotonin by small amounts of tyrosinase and serum.
Tyrosinase and Other Pressor Substances.-Tyrosinase inactivates adre- 
nalin in vitro almost instantaneously. Tyramine is likewise inactivated although less rapidly. When tyrosinase had been given to a dog or rat, the subsequent injection of tyramine or adrenalin resulted in a modified response, characterized by less elevation of the blood pressure of shorter duration, and sometimes by transient depression of blood pressure after the pressor effect was over. A quantity of the pressor material obtained from the anaerobic autolysate of renal tissue, prepared by Dr. Joseph Victor, was used in various experiments. Tyrosinase was found to render this material inactive both for dogs and rats. When it was shaken with tyrosinase at room temperature, a depressor response upon injection was noticed in all of six rats and two normal dogs. The presence of catechol-hydroquinone solution was not necessary for this change in effect. The injection of tyrosinase into an animal was found to modify the pressor response of this material when injected subsequently; similarly, the injection of tyrosinase at the height of the pressor response resulted in a fall in blood pressure. In one hypertensive dog, the injection of tyrosinase was found to abolish both the hypertensive state and the further elevation of blood pressure which had resulted from the administration of Victor's material.
Renal blood flow in four normal dogs, measured by the thermostromuhr, was at first reduced after the injection of tyrosinase, and then increased. The reaction of the blood flow to adrenalin by the ischemic kidney was reversed in two experiments, vasoconstriction being replaced by vasodilatation. Hypertension which had resulted from partial constriction of the renal artery and the injection of adrenalin (11) was abolished.
Reactions.-Various reactions followed the intravenous administration of tyrosinase. Anesthetized rats, whether normal or hypertensive, consistently exhibited bradycardia 5 to 15 minutes after the injection, the lowered cardiac rate remaining while the rats were observed (up to 2 hours) and sometimes persisting for 24 hours. A few animals exhibited diarrhea for a day or two after injection. Anesthetized dogs with hypertension developed bradycardia a few minutes after injection. Unanesthetized dogs, normal and hypertensive, exhibited vomiting, diarrhea, tenesmus, and slowing of the pulse, 5 to 30 minutes after injection, lasting one to two hours. The intestines of one animal were seen to be markedly contracted. It was also noticed that excited dogs quieted while the injection was being given. Reactions of this nature were greater in hypertensive dogs, sometimes altering their general behavior; normal ones were less affected. These events did not occur if atropine had been injected. Tyrosinase, in rats and dogs, acted therefore like a cholinergic drug. Little or no change was seen in the behavior of normal rabbits, guinea pigs, or monkeys after intravenous injection, but the blood pressure was not estimated.
The Antigenicity of Tyrosinase
The preparation of tyrosinase used is a good antigen in rabbits. A strong antiserum was prepared and precipitins were detectable at an antigen dilution of 1:400,000. When a solution of tyrosinase was precipitated by this serum, most (9/10ths) of the activity of the enzyme was removed. The precipitate was, however, readily soluble in water and upon solution the enzyme became completely active.
Six guinea pigs were sensitized to tyrosinase by repeated intraperitoneal injections. Subsequent intravenous injections failed to produce signs of anaphylaxis. Sensitized rabbits likewise showed no signs of anaphylaxis after intravenous injection.
The Effect of Other Enzymes on Hypertension
Two enzymes having the property of attacking the guanidine linkage in such compounds as arginine, guanidine, and creatinine were injected into 14 rats and four dogs. Arginase obtained from Dr. Ren6 J. Dubos and prepared by him from soil bacteria was found to raise blood pressure in hypertensive animals while that of normal ones was less affected. Arginase prepared from livers was found to have a similar action, although less pronounced. Both preparations were far from pure, and no conclusions can be drawn from these results.
DISCUSSION
From these experiments there is little doubt that the injection of this preparation of tyrosinase in suitable doses into rats and dogs exhibiting experimental hypertension of the renal variety results in reduction of the blood pressure. Furthermore, there is a difference in the response of normal animals, their blood pressure being less or not at all affected. Although the possibility exists that the hypotensive action of this enzyme is a non-specific one, the most probable explanation of this phenomenon is that some substance present in the hypertensive state is altered. Because tyrosinase acts only on compounds containing a mono-or ortho-di-hydroxybenzene structure in the molecule, the substance which is changed must contain a phenolic group of this nature.
Two possibilities come to mind: the pressor substance itself is inactivated by or through the medium of the enzyme, or some other compound, probably phenolic, is altered to form a depressor substance. From what is known of pressor substances in arterial hypertension the first explanation is more likely; there is no evidence for the second.
There are at least three possible ways in which tyrosinase may act. First, all compounds containing catechol or phenolic configurations are probably oxidized by the enzyme to quinones. This change from the benzenoid to the quinoid configuration is accompanied by an alteration in the physiological action of the compound concerned, as is well illustrated in the case of adrenalin and tyramine. In this way tyrosinase may destroy some as yet unknown phenolic pressor substance which is responsible for hypertension.
A second possibility is that the orthoquinones produced by the action of tyrosinase on phenolic substances have special properties. These orthoquinones, being powerful oxidizing agents, may themselves destroy some pressor substance of lower oxidation-reduction potential in a manner analogous to the destruction of ascorbic acid by orthoquinones (12) . These substances themselves can oxidize amines.
The third explanation is that adrenalin is destroyed. Arterial hypertension can be produced in brief experiments by very small amounts of this hormone if one kidney is ischemic. Adrenalin in these amounts is a powerful renal vasoconstrictor in dogs (11) . Destruction of adrenalin may allow renal vasodilatation. In that event the blood pressure would fall.
By whatever method tyrosinase acts, it appears to have an action specific for arterial hypertension of the variety produced in these experiments. Furthermore, it inactivates various pressor substances. The part that these materials play in the existence of hypertension is not known, but each behaves as a pressor substance conceivably responsible for bringing on elevation of the blood pressure.
It was shown that renin was inactivated by tyrosinase under certain conditions, that is, when catechol or when some product of the deterioration of renin was present. Tyrosinase acts upon catechol to form orthoquinone, which is an oxidizing agent. It is likely, therefore, that the inactivation of renin depends upon the non-specific action of another substance. The significance of an event such as this in the bodies of animals is unknown. If renin were concerned in hypertension it might be inactivated in this manner.
Under certain conditions angiotonin is also inactivated by tyrosinase, that is, when serum is present. This reaction does not depend upon the presence of catechol. Although the preparation of angiotonin used was acted upon directly by the enzyme, the reaction was complete only after the addition of serum. Angiotonin according to Page (3) must be activated by some substance present in serum. These results suggest that the product of the activation of angiotonin is a phenolic substance.
Victor's substance, likewise, in the preparations obtained, was inactivated directly by tyrosinase, suggesting that this material also contains a phenolic configuration. The inactivation of adrenalin and tyramine is accomplished by direct action of the enzyme.
Light is thrown on at least one part of the action of tyrosinase by the nature of the various reactions which follow intravenous injection. These effects suggest that tyrosinase acts as a cholinergic drug. This enzyme, however, alters sympathicomimetic substances. The more likely explanation, therefore, is that the sympathetic nervous system is depressed.
There is no explanation for the lowering of the urea nitrogen in the blood of dogs. This change was seen consistently, and did not depend upon a change in amino acids. The least that can be said is that renal insufficiency did not accompany the lowered blood pressure.
The antigenic action of tyrosinase presents a difficultproblem. Although it does not occasion anaphylactic shock in guinea pigs, and dogs developed no signs of sensitivity even after 5 months of intermittent use, antibodies (precipitins) have been demonstrated in human beings after subcutaneous injection. Further studies on this subject, both in animals and in human beings, are in progress.
From these studies it becomes obvious that the use of tyrosinase, an enzyme specific in altering phenolic compounds, effectively combats arterial hypertension induced by various methods in rats and in dogs. The use of this enzyme in human beings is now being investigated.
CONCLUSIONS
1. The intravenous injection of tyrosinase, a phenolic oxidase obtained from mushrooms, consistently lowers the blood pressure of rats made hypertensive by three different methods, while on the average not affecting the blood pressure of normal animals.
2. The intravenous and intramuscular injection of tyrosinase lowers blood pressure in dogs made hypertensive by the method of Goldblatt, while affecting that of normal ones to a less extent.
3. Tyrosinase inactivates renin, angiotonin, Victor's pressor substance, adrenalin, and tyramine in vitro, and alters the response of the blood pressure to these substances in rats and dogs.
4. Renal function of hypertensive dogs is not depressed when the blood pressure is lowered by tyrosinase.
5. Tyrosinase is an effective substance for combating experimental arterial hypertension. It is probable that some phenolic substance present in hypertension is altered.
After this paper was submitted for publication, a second sample of angiotonin was received from Dr. Page, and the effect of tyrosinase upon it ascertained. Serum was not necessary in this instance for complete inactivation of its pressor action by small amounts of tyrosinase. Amounts of the enzyme as small as 0.2 units abolished the pressor effect of one "rat dose" of this solution of angiotonin, and caused approximately equal absorption of oxygen in the presence and absence of serum. The first curve shows the effect on blood pressure of one rat dose of angiotonin. The pulse pressure has increased. One rat dose of angiotonin and 500 units of tyrosinase, shaken at room temperature for 20 minutes were then administered. There was a decrease in the activity of the former. The third curve shows the effect of the mixture when catechol was added. Angiotonin was still active. In the fourth curve, a mixture of angiotonin, tyrosinase, and serum was injected. Very little activity on blood pressure resulted. The last curve again shows the effect of angiotonin alone. The rat was made hypertensive by the production of unilateral hydronephrosis; notice the fall in the level of blood pressure after the first injection of tyrosinase. B, rat 67, normal. The inactivation of angiotonin by small amounts of tyrosinase. The first curve shows the effect on blood pressure of one rat dose of angiotonin and 6 mg. gelatin which had been shaken in the Warburg apparatus. The second demonstrates the effect of the same amount of angiotonin, 0.1 cc. serum, and 2.5 units of tyrosinase similarly treated. Angiotonin was inactive. In the third curve is seen the effect when gelatin was substituted for serum. The last curve shows the effect of tyrosinase and gelatin, an inert mixture.
